CVSA
Covista Inc.
NYSE · Consumer Cyclical · Personal Products & Services · US
$128.08
+0.34%Year over year
Reported trailing growth
- Revenue
- +9.3%
- EBITDA
- +13.1%
- EBIT
- +14.6%
- EPS
- +21.0%
- Free cash flow
- +36.6%
- Operating cash flow
- +39.2%
Forward estimates
Based on analyst estimates
- Revenue
- +6.0%
- EBITDA
- +8.9%
- EPS
- +19.9%
Three-year CAGR
- Revenue
- +10.4%
- EBITDA
- +12.7%
- EBIT
- +19.9%
- Net income
- +37.4%
- EPS
- +46.8%
- Free cash flow
- +33.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026